BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 32187846)

  • 1. XEN-augmented Baerveldt surgical success rate and comparison with the Ahmed Valve.
    Teixeira FJ; Sousa DC; Machado NM; Caiado F; Barão R; Sens P; Abegão Pinto L
    Acta Ophthalmol; 2020 Nov; 98(7):e870-e875. PubMed ID: 32187846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XEN-augmented Baerveldt drainage device implantation in refractory glaucoma: 1-year outcomes.
    Bravetti GE; Mansouri K; Gillmann K; Rao HL; Mermoud A
    Graefes Arch Clin Exp Ophthalmol; 2020 Aug; 258(8):1787-1794. PubMed ID: 32377823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ahmed Versus Baerveldt Study: Five-Year Treatment Outcomes.
    Christakis PG; Kalenak JW; Tsai JC; Zurakowski D; Kammer JA; Harasymowycz PJ; Mura JJ; Cantor LB; Ahmed II
    Ophthalmology; 2016 Oct; 123(10):2093-102. PubMed ID: 27544023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant.
    Goulet RJ; Phan AD; Cantor LB; WuDunn D
    Ophthalmology; 2008 Jul; 115(7):1141-7. PubMed ID: 18164068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ahmed Versus Baerveldt Glaucoma Drainage Device in Uveitic Glaucoma: A Retrospective Comparative Study.
    Sinha S; Ganjei AY; McWatters Z; Lee D; Moster MR; Myers JS; Kolomeyer N; Mantravadi AV; Pro MJ; Razeghinejad R
    J Glaucoma; 2020 Sep; 29(9):750-755. PubMed ID: 32590449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up.
    Budenz DL; Barton K; Feuer WJ; Schiffman J; Costa VP; Godfrey DG; Buys YM;
    Ophthalmology; 2011 Mar; 118(3):443-52. PubMed ID: 20932583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year treatment outcomes in the Ahmed Baerveldt comparison study.
    Budenz DL; Barton K; Gedde SJ; Feuer WJ; Schiffman J; Costa VP; Godfrey DG; Buys YM;
    Ophthalmology; 2015 Feb; 122(2):308-16. PubMed ID: 25439606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ahmed versus Baerveldt study: three-year treatment outcomes.
    Christakis PG; Tsai JC; Kalenak JW; Zurakowski D; Cantor LB; Kammer JA; Ahmed II
    Ophthalmology; 2013 Nov; 120(11):2232-40. PubMed ID: 23796764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-year treatment outcomes in the Ahmed Baerveldt comparison study.
    Barton K; Feuer WJ; Budenz DL; Schiffman J; Costa VP; Godfrey DG; Buys YM;
    Ophthalmology; 2014 Aug; 121(8):1547-57.e1. PubMed ID: 24768240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized controlled study of Aurolab aqueous drainage implant versus Ahmed glaucoma valve in refractory glaucoma: A pilot study.
    Rathi SG; Seth NG; Kaur S; Thattaruthody F; Kaushik S; Raj S; Pandav SS; Ram J
    Indian J Ophthalmol; 2018 Nov; 66(11):1580-1585. PubMed ID: 30355865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XEN-augmented Baerveldt Implantation for Refractory Childhood Glaucoma: A Retrospective Case Series.
    Arad T; Hoffmann EM; Prokosch-Willing V; Pfeiffer N; Grehn F
    J Glaucoma; 2019 Nov; 28(11):1015-1018. PubMed ID: 31460883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-Year Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study.
    Christakis PG; Zhang D; Budenz DL; Barton K; Tsai JC; Ahmed IIK;
    Am J Ophthalmol; 2017 Apr; 176():118-126. PubMed ID: 28104418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Combined Ahmed Glaucoma Valve and Trabeculectomy Revision With Adjunctive Antimetabolite.
    Lin M; Alizadeh R; Law SK
    J Glaucoma; 2019 May; 28(5):404-410. PubMed ID: 31048638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon.
    Tsai JC; Johnson CC; Kammer JA; Dietrich MS
    Ophthalmology; 2006 Jun; 113(6):913-7. PubMed ID: 16751034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Ahmed Versus Baerveldt study: one-year treatment outcomes.
    Christakis PG; Kalenak JW; Zurakowski D; Tsai JC; Kammer JA; Harasymowycz PJ; Ahmed II
    Ophthalmology; 2011 Nov; 118(11):2180-9. PubMed ID: 21889801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two Year Randomized Prospective Comparison of Ahmed Valve Versus Baerveldt Implant in Vitrectomized Eyes.
    Kandarakis SA; Petrou P; Katsimpris A; Papakonstantinou E; Timpilis M; Chronopoulou K; Lehman A; Ifantides C; Georgalas I
    J Glaucoma; 2023 Jan; 32(1):27-33. PubMed ID: 36223288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Trabeculectomy and Ahmed Glaucoma Valve Implantation in Patients With Iridocorneal Endothelial Syndrome.
    Nilforushan N; Abolfathzadeh N; Miraftabi A; Banifatemi M
    J Glaucoma; 2024 Jul; 33(7):e35-e42. PubMed ID: 38506803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baerveldt-350 implant versus Ahmed valve for refractory glaucoma: a case-controlled comparison.
    Syed HM; Law SK; Nam SH; Li G; Caprioli J; Coleman A
    J Glaucoma; 2004 Feb; 13(1):38-45. PubMed ID: 14704542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 1-year outcomes after Ahmed glaucoma valve implantation with and without Ologen adjuvant.
    Kim TJ; Kang S; Jeoung JW; Kim YK; Park KH
    BMC Ophthalmol; 2018 Feb; 18(1):45. PubMed ID: 29444665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta-analysis.
    Wang S; Gao X; Qian N
    BMC Ophthalmol; 2016 Jun; 16():83. PubMed ID: 27277579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.